Pfizer CEO Says Covid Is ‘Irrelevant.’ He’s Betting on Cancer and Weight-Loss Drugs.
Pfizer boosts full-year guidance on the back of its latest quarter, citing growth in non-Covid offerings and acquired products.
Pfizer boosts full-year guidance on the back of its latest quarter, citing growth in non-Covid offerings and acquired products.